Alert button
Picture for Michael Widrich

Michael Widrich

Alert button

Cross-Domain Few-Shot Learning by Representation Fusion

Oct 13, 2020
Thomas Adler, Johannes Brandstetter, Michael Widrich, Andreas Mayr, David Kreil, Michael Kopp, Günter Klambauer, Sepp Hochreiter

Figure 1 for Cross-Domain Few-Shot Learning by Representation Fusion
Figure 2 for Cross-Domain Few-Shot Learning by Representation Fusion
Figure 3 for Cross-Domain Few-Shot Learning by Representation Fusion
Figure 4 for Cross-Domain Few-Shot Learning by Representation Fusion
Viaarxiv icon

Modern Hopfield Networks and Attention for Immune Repertoire Classification

Jul 16, 2020
Michael Widrich, Bernhard Schäfl, Hubert Ramsauer, Milena Pavlović, Lukas Gruber, Markus Holzleitner, Johannes Brandstetter, Geir Kjetil Sandve, Victor Greiff, Sepp Hochreiter, Günter Klambauer

Figure 1 for Modern Hopfield Networks and Attention for Immune Repertoire Classification
Figure 2 for Modern Hopfield Networks and Attention for Immune Repertoire Classification
Figure 3 for Modern Hopfield Networks and Attention for Immune Repertoire Classification
Figure 4 for Modern Hopfield Networks and Attention for Immune Repertoire Classification
Viaarxiv icon

Hopfield Networks is All You Need

Jul 16, 2020
Hubert Ramsauer, Bernhard Schäfl, Johannes Lehner, Philipp Seidl, Michael Widrich, Lukas Gruber, Markus Holzleitner, Milena Pavlović, Geir Kjetil Sandve, Victor Greiff, David Kreil, Michael Kopp, Günter Klambauer, Johannes Brandstetter, Sepp Hochreiter

Figure 1 for Hopfield Networks is All You Need
Figure 2 for Hopfield Networks is All You Need
Figure 3 for Hopfield Networks is All You Need
Viaarxiv icon

Large-scale ligand-based virtual screening for SARS-CoV-2 inhibitors using deep neural networks

Apr 03, 2020
Markus Hofmarcher, Andreas Mayr, Elisabeth Rumetshofer, Peter Ruch, Philipp Renz, Johannes Schimunek, Philipp Seidl, Andreu Vall, Michael Widrich, Sepp Hochreiter, Günter Klambauer

Figure 1 for Large-scale ligand-based virtual screening for SARS-CoV-2 inhibitors using deep neural networks
Figure 2 for Large-scale ligand-based virtual screening for SARS-CoV-2 inhibitors using deep neural networks
Figure 3 for Large-scale ligand-based virtual screening for SARS-CoV-2 inhibitors using deep neural networks
Figure 4 for Large-scale ligand-based virtual screening for SARS-CoV-2 inhibitors using deep neural networks
Viaarxiv icon

Explaining and Interpreting LSTMs

Sep 25, 2019
Leila Arras, Jose A. Arjona-Medina, Michael Widrich, Grégoire Montavon, Michael Gillhofer, Klaus-Robert Müller, Sepp Hochreiter, Wojciech Samek

Figure 1 for Explaining and Interpreting LSTMs
Figure 2 for Explaining and Interpreting LSTMs
Figure 3 for Explaining and Interpreting LSTMs
Figure 4 for Explaining and Interpreting LSTMs
Viaarxiv icon

RUDDER: Return Decomposition for Delayed Rewards

Jun 20, 2018
Jose A. Arjona-Medina, Michael Gillhofer, Michael Widrich, Thomas Unterthiner, Sepp Hochreiter

Figure 1 for RUDDER: Return Decomposition for Delayed Rewards
Figure 2 for RUDDER: Return Decomposition for Delayed Rewards
Figure 3 for RUDDER: Return Decomposition for Delayed Rewards
Figure 4 for RUDDER: Return Decomposition for Delayed Rewards
Viaarxiv icon